Table 3.
Demographic and clinical data of the participants
| GENERAL INFORMATION | |||
|---|---|---|---|
| ID | 01 | 02 | 03 |
| Sex | F | M | M |
| Age | 114 | 111 | 110 |
| Year of birth | 1906 | 1910 | 1911 |
| Life status | Death on Feb 2021, as a consequence of urinary tract infection | Death in Nov 2021 from natural causes | Still alive |
| Comorbidities* | Dementia | Diabetes mellitus | Hypertension |
| Covid-19-RELATED EVENTS | |||
| SARS-CoV-2 exposure/ beginning of symptoms | August 2020 | June 2020 | May 2020 |
| Disease severity** | Moderate | Asymptomatic | Moderate |
| Hospital admission and discharge |
Hospital admission on Aug 31, 2020 ICU admission necessary |
Not applicable |
Hospital admission in June 2020 ICU admission necessary Hospital discharge after 18 days |
| Positive SARS-CoV-2 serology |
Sep 2020 MAGLUMI 2019 nCoV IgM and IgM reagents |
Jan 2021 ELISA IgM and IgG anti-Spike and anti-NP (Table 1) |
Jun 2021 ELISA IgM and IgG anti-Spike and anti-NP (Table 1) |